Cognitive enhancing drugs: neuroethical issues
Presenter: Barbara Sahakian
Published: January 2010
Age: 18-22 and upwards
Views: 1370 views
Source/institution: Royal Society
Cognitive enhancing drugs are used to treat neuropsychiatric disorders such as Alzheimer’s disease, schizophrenia and attention deficit hyperactivity disorder. These drugs improve the quality of life and wellbeing for patients and their families.